TipRanks
Advertisement
Advertisement
Healios Files Counterclaim in Payment Dispute with AND Medical
PremiumCompany AnnouncementsHealios Files Counterclaim in Payment Dispute with AND Medical
4M ago
Healios Highlights Uncertainty Around FY2026 Q1 Disclosures and Outlook
Premium
Company Announcements
Healios Highlights Uncertainty Around FY2026 Q1 Disclosures and Outlook
5M ago
Healios Signs ¥144 Million Stem Cell Supernatant Supply Deal With JENECELL
Premium
Company Announcements
Healios Signs ¥144 Million Stem Cell Supernatant Supply Deal With JENECELL
6M ago
Healios Launches Japan Arm of Global Phase 3 Trial for ARDS Stem Cell Therapy
PremiumCompany AnnouncementsHealios Launches Japan Arm of Global Phase 3 Trial for ARDS Stem Cell Therapy
8M ago
Healios Deepens Alfresa Alliance for Stem Cell Culture Supernatant Distribution in Japan
Premium
Company Announcements
Healios Deepens Alfresa Alliance for Stem Cell Culture Supernatant Distribution in Japan
9M ago
Healios Files Japan Trial Plan for Global Phase 3 ARDS Stem Cell Study
Premium
Company Announcements
Healios Files Japan Trial Plan for Global Phase 3 ARDS Stem Cell Study
9M ago
Healios Partners with Kyushu University for Brain Tumor Therapy Research
PremiumCompany AnnouncementsHealios Partners with Kyushu University for Brain Tumor Therapy Research
1y ago
Healios Ends Alliance with Nikon, Plans CDMO Expansion
Premium
Company Announcements
Healios Ends Alliance with Nikon, Plans CDMO Expansion
1y ago
Healios Secures Patent Approval for Universal Donor Cells in Japan
Premium
Company Announcements
Healios Secures Patent Approval for Universal Donor Cells in Japan
1y ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―